Modulating IL-6 and IL-10 levels by pharmacologic strategies and the impact of different extracorporeal circulation parameters during cardiac surgery

Shock

Volumn 16, Issue SUPPL., 2001, Pages 33-38

  Harig, Frank ^a   Hohenstein, Bernd ^a   Von Der Emde, Jürgen ^a   Weyand, Michael ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Cardiac surgery; Correlation; Extracorporeal circulation; IL 10; IL 6; Inflammatory response; Modulation

Indexed keywords

APROTININ; HEPARIN; INTERLEUKIN 10; INTERLEUKIN 6; OXYGEN; PREDNISOLONE;

AGED; ARTICLE; BLOOD; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CRYOANESTHESIA; EXTRACORPOREAL CIRCULATION; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TIME;

AGED; APROTININ; BLOOD PRESSURE; CORONARY ARTERY BYPASS; EXTRACORPOREAL CIRCULATION; FEMALE; HEPARIN; HUMANS; HYPOTHERMIA, INDUCED; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; OXYGEN; PREDNISOLONE; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 0035237554     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200116001-00007     Document Type: Article

References (40)

1. Butler J, Rocker GM, Westaby S: Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 55:552-559, 1993.
2. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD: Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 86:845-857, 1983.
3. Casey LC: Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann Thorac Surg 56:S92-S96, 1993.
4. Taylor KM: SIRS: the systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 61:1607-1608, 1996.
5. Steinberg JB, Kapelanski DP, Olson JD, Weiler JM: Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 106:1008-1016, 1993.
6. Boyle Jr EM, Pohlman TH, Johnson MC, Verrier ED: The systemic inflammatory response. Ann Thorac Surg 64:31-37, 1997.
7. Dehoux M, Philip I, Chollet-Martin S, Boutten A, Hvass U, Desmonts JM, Durand G: Early production of interleukin-10 during normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg 110:286-287, 1995.
8. Gerard C, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, Delvaux A, Fiers W, Goldman M, Velu T: Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxinaemia. J Exp Med 177:547-550, 1993.
9. Wang P, Wu P, Anthes JC, Siegel MI, Egan RW, Billah MM: Interleukin-10 inhibits interleukin-8 production in human neutrophils. Blood 83:2678-2683, 1994.
10. Van der Poll T, Jansen I, Levi M, ten Cate H, Hack CE, Aarden LA, ten Cate JW, van Deventer SJ: Interleukin-10 release during endotoxinaemia in chimpanzees: role of platelet-activating factor and IL-6. Scand J Immunol 43:122-125, 1996.
11. Mosmann TR, Schumacher JH, Street NF, Budd R, O'Garra A, Fong TA, Bond MW, Moore KW, Sher A, Fiorentino DF: IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815-3822, 1991.
12. Eppinger MJ, Ward PA, Boiling SF, Deeb GM: Regulatory effects of Interleukin-10 on lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 112: 1301-1306, 1996.
13. McBride WT, Armstrong MA, Crockard AD, McMurray TJ, Rea JM: Cytokine balance and immunosuppressive changes at cardiac surgery: contrasting response between patients and isolated CPB circuits. Br J Anaesthesiol 75:724-733, 1995.
14. Hermus A, Sweep C: Cytokines and the hypothalamic-pituitary-adrenal axis. J Steroid Biochem Mol Biol 37:867-871, 1990.
15. Harig F, Hohenstein B, von der Emde J: Immunomonitoring during and after CPB for analysis of cytokine secretion patterns and developing of a preventive strategy of SIRS after cardiac surgery. Thorac Cardiovasc Surgeon 45:65, 1997.
16. Cremer J, Martin M, Redl H, Bahrami S, Abraham C, Graeter T, Haverich A, Schlag G, Borst HG: Systemic inflammatory response after cardiac operations. Ann Thorac Surg 61:1714-1720, 1996.
17. Royston D, Bidstrup BP, Taylor KM, Sapsford RN: Effect of aprotinin on need for blood transfusion after repeat open-heart surgery, Lancet 2:1289-1291, 1987.
18. Bidstrup BP, Royston D, Sapsford RN, Taylor KM: Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). J Thorac Cardiovasc Surg 97:364-372, 1989.
19. De Waal Malefyt R, Abrams J, Benett B, Figdor CG, De Vries JE: Interleukin-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220, 1991.
20. Wan S, Marchant A, DeSmet JM, Antoine M, Zhang H, Vachiery JL, Goldman M, Vincent JL, LeClerc JL: Human cytokine responses to cardiac transplantation and coronary artery bypass grafting. J Thor Cardiovasc Surg 111:469-477, 1996.
21. Le Moine O, Marchant A, Durand F, Ickx B, Pradier O, Belghiti J, Abramowicz D, Gelin M, Goldman M, Deviere J: Systemic release of interleukin-10 during orthotopic liver transplantation. Hepatology 20:889-892, 1994.
22. Menasche P, Haydar S, Peynet J, Du Buit C, Merval R, Bloch G, Piwnica A, Tedgui A: A potential mechanism of vasodilatation after warm heart surgery: the temperature-dependent release of cytokines. J Thorac Cardiovasc Surg 107:293-299, 1994.
23. Schluter B, Konig B, Bergmann U, Muller FE, Konig W: Interleukin-6: a potential mediator of lethal sepsis after major thermal trauma. Evidence for increased IL-6 production by peripheral blood mononuclear cells. J Trauma 31:1663-1670, 1991.
24. Harig F: Induction of secondary cytokines by cultivation of peripheral mono-nuclear cells with interleukin-2 and other cytokines and modulation of killer cell activity by combinations of cytokines in vitro. PhD Thesis. Johann Wolfgang Goethe-University Frankfurt a.M. Medical Faculty, 1996.
25. Engelman R, Rousou J, Flack J, Deaton D, Kalfin R, Das D: Influence of steroids on complement and cytokine generation after cardiopulmonary bypass. Ann Thorac Surg 60:801-804, 1995.
26. Mayumi H, Zhang QW, Nakashima A, Masuda M, Kohno H, Kawachi Y, Yasui H: Synergistic immunosuppression caused by high dose methylprednisolon and cardiopulmonary bypass. Ann Thorc Surg 63:129-137, 1997.
27. Gschoßmann J, Pracki P, Struck E: Application of proteinase inhibitor aprotinin during cardiac surgery using autotransfusion. Z Herz-, Thorax-, Gefäßchir 8: 240-244, 1994.
28. Ashraf S, Tian Y, Cowan D, Nair U, Chatrath R, Saunders NR, Watterson KG, Martin PG: Low-dose aprotinin modifies hemostasis but not proinflammatory cytokine release. Ann Thorac Surg 63:68-73, 1997.
29. Sundt TM III, Kouchoukos NT, Saffitz JE, Murphy SF, Wareing TH, Stahl DJ: Renal dysfunction and intravascular coagulation with aprotinin and hypothermie circulatory arrest. Ann Thorac Surg 55:1418-1424, 1993.
30. Dietrich W, Späth P, Ebell A, Richter JA: Prevalence of anaphylactic reactions to aprotinin: analysis of 248 re-exposures to aprotinin in heart operations. J Thorac Cardiovasc Surg 113:194-201, 1997.
31. Steinberg BM, Grossi EA, Schwartz DS, McLoughlin DE, Aguinaga M, Bizekis C, Greenwald J, Flisser A, Spencer FC, Galloway AC, et al.: Heparin-bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass. Ann Thorac Surg 60:525-529, 1995.
32. Lundblad R, Moen O, Fosse E: Endothelin-1 and neutrophil activation during heparin-coated cardiopulmonary bypass. Ann Thorac Surg 63:1361-1367, 1997.
33. Baufreton C, Jansen PG, Le Besnerais P, te Velthuis H, Thijs CM, Wildevuur CR, Loisance DY: Heparin coating with aprotinin reduces blood activation during coronary artery operations. Ann Thorac Surg 63:50-56, 1997.
34. Struber M, Cremer JT, Gohrbandt B, Hagl C, Jankowski M, Volker B, Ruckoldt H, Martin M, Haverich A: Human cytokine response to coronary artery bypass grafting with and without CPB cardiopulmonary bypass. Ann Thor Surg 68: 1330-1335, 1999.
35. Belboul A, Akbar O, Loefgren C, Jungbeck M, Storm C, Roberts A: Improved blood cellular biocompatibility with heparin-coated circuits during cardiopulmonary bypass. J Cardiovasc Surg 41:357-362, 2000.
36. Belbou A, Loefgren C, Storm C, Jungbeck M: Heparin-coated circuits reduce occult myocardial damage during CPB: a randomized, single blind clinical trial. Eur J Cardiothor Surg 17:580-586, 2000.
37. Olsson C, Siegbahn A, Haldén E, Nilsson B, Venge P, Thelin S: No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits. Ann Thor Surg 69:743-749, 2000.
38. Taylor KM, Bain WH, Jones JV, Walker MS: The effect of hemodilution on plasma levels of cortisol and free cortisol. J Thorac Cardiovasc Surg 72:57-61, 1976.
39. Roth-Isrigkeit A, von Borstel T, Seyfarth M, Schmucker P: Perioperative serum levels of tumor necrosis factor-alpha (TNF-α), IL-1β, IL-6, IL-10, and soluble IL-2 receptor in patients undergoing cardiac surgery with cardiopulmonary bypass without and with correction for haemodilution. Clin Exp Immunol 118: 242-246, 1999.
40. Hill GE, Diego RP, Stammers AH, Huffman SM, Pohorecki R: Aprotinin enhances the endogenous release of interleukin-10 after cardiac operations. Ann Thor Surg 65:66-69, 1998.